Drug intelligence / Profile preview

Xiluoming Zhengqing Fengtongning Tablets

Development stage
Unknown
Lead developer
Zhengqing Pharmaceutical Group
Modality
Small Molecules
Administration
Oral
01

Overview

Xiluoming Zhengqing Fengtongning Tablets is an anti-rheumatic traditional Chinese medicine (TCM) formulation developed and manufactured by Hunan Zhengqing Pharmaceutical (also referred to as Hunan Zhongqi Pharmaceutical). The active ingredient is sinomenine hydrochloride, a monomeric alkaloid extracted from the root and stem of *Sinomenium acutum*. It is approved in China for the treatment of rheumatic diseases, including rheumatoid arthritis and osteoarthritis, presenting with wind-cold-dampness arthralgia syndrome (characterized by muscle soreness, joint swelling, pain, and stiffness). Sinomenine hydrochloride exerts anti-inflammatory, analgesic, and immunomodulatory effects, primarily by acting as an agonist of the mu-type opioid receptor and downregulating the NF-κB signaling pathway, which subsequently reduces the production of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.

Brand names
XiluomingZhengqing Fengtongning
Other names
Xiluoming Zhengqing Fentongning Tablets 100Zhengqing Fengtongning Tabletssinomenine hydrochloride tablets正清风痛宁片盐酸青藤碱片
02

Targets

IL1B (Interleukin-1 beta)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Xiluoming Zhengqing Fengtongning Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiluoming Zhengqing Fengtongning Tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call